In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion

Journal of Neuroscience Research

Volumn 82, Issue 3, 2005, Pages 404-412

  Grider, M H ^a   Mamounas, L A ^b   Le, W ^a   Shine, H David ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NONE   (United States)

Author keywords

Adenoviral vector; Axonal sprouting; Neurotrophin; Plasticity; Serotonin

Indexed keywords

ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORAMPHETAMINE; COMPLEMENTARY DNA; ENHANCED GREEN FLUORESCENT PROTEIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NERVE FIBER; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONINERGIC NERVE CELL;

ANIMALS; BRAIN DISEASES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; GROWTH CONES; NERVE GROWTH FACTOR; NERVE REGENERATION; NEURAL PATHWAYS; NEURONAL PLASTICITY; NEUROTOXINS; NEUROTROPHIN 3; P-CHLOROAMPHETAMINE; RAPHE NUCLEI; RATS; SEROTONIN; TRANSFECTION; UP-REGULATION;

EID: 27644549457     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20635     Document Type: Article

References (38)

1. Azmitia EC, Dolan K, Whitaker-Azmitia PM. 1990. S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor. Brain Res 516:354-356.
2. Baumgartner BJ, Shine HD. 1997. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci 17:6504-6511.
3. Bostwick JR, Le WD. 1991. A tyrosine hydroxylase assay in microwells using coupled nonenzymatic decarboxylation of dopa. Anal Biochem 192:125-130.
4. Bregman BS, Coumans JV, Dai HN, Kuhn PL, Lynskey J, McAtee M, Sandhu F. 2002. Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog Brain Res 137:257-273.
5. Brown P, Molliver ME. 2000. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J Neurosci 20:1952-1963.
6. Chalon S, Bronquard C, Vercouillie J, Kodas E, Garreau L, Bodard S, Emond P, Besnard JC, Guilloteau D. 2004. ADAM is an effective tool for in vivo study of serotonergic function: validation in rat models. Synapse 52:136-142.
7. Finkelstein DI, Stanic D, Parish CL, Tomas D, Dickson K, Home MK. 2000. Axonal sprouting following lesions of the rat substantia nigra. Neuroscience 97:99-112.
8. Frangi AF, Niessen WJ, Hoogeveen RM, van Walsum T, Viergever MA. 1999. Model-based quantitation of 3-D magnetic resonance angiographic images. IEEE Trans Med Imaging 18:946-956.
9. Hains BC, Everhart AW, Fullwood SD, Hulsebosch CE. 2002. Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Exp Neurol 175:347-362.
10. Haring JH, Meyerson L, Hoffman TL. 1992. Effects of parachloroamphetamine upon the serotonergic innervation of the rat hippocampus. Brain Res 577:253-260.
11. Hory-Lee F, Russell M, Lindsay RM, Frank E. 1993. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci U S A 90:2613-2617.
12. Kawaja MD, Gage FH. 1991. Reactive astrocytes are substrates for the growth of adult CNS axons in the presence of elevated levels of nerve growth factor. Neuron 7:1019-1030.
13. Kerschensteiner M, Bareyre FM, Buddeberg BS, Merkler D, Stadelmann C, Bruck W, Misgeld T, Schwab ME. 2004. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med 200:1027-1038.
14. Kim DW, Uetsuki T, Kaziro Y, Yamaguchi N, Sugano S. 1990. Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 91:217-223.
15. Kuchel GA, Zigmond RE. 1991. Functional recovery and collateral neuronal sprouting examined in young and aged rats following a partial neural lesion. Brain Res 540:195-203.
16. 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography. J Nucl Med 45:673-681.
17. Madhav TR, Pei Q, Zetterstrom TS. 2001. Serotonergic cells of the rat raphe nuclei express mRNA of tyrosine kinase B (trkB), the high-affinity receptor for brain derived neurotrophic factor. Brain Res Mol Brain Res 93:56-63.
18. Mamounas LA, Molliver ME. 1988. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp Neurol 102:23-36.
19. Mamounas LA, Mullen CA, O'Hearn E, Molliver ME. 1991. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol 314:558-586.
20. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE. 2000. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20:771-782.
21. Molliver ME, Mamounas LA, Wilson MA. 1989. Effects of neurotoxic amphetamines on serotonergic neurons: immunocytochemical studies. NIDA Res Monogr 94:270-305.
22. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
23. Navarro V, Millecamps S, Geoffroy MC, Robert JJ, Valin A, Mallet J, Gal La Salle GL. 1999. Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter. Gene Ther 6:1884-1892.
24. Papadopoulos GC, Parnavelas JG, Buijs RM. 1987. Light and electron microscopic immunocytochemical analysis of the serotonin innervation of the rat visual cortex. J Neurocytol 16:883-892.
25. Paspalas CD, Papadopoulos GC. 2001. Serotoninergic afferents preferentially innervate distinct subclasses of peptidergic interneurons in the rat visual cortex. Brain Res 891:158-167.
26. Patapoutian A, Reichardt LF. 2001. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11:272-280.
27. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. San Diego: Academic Press Inc.
28. Poduslo JF, Curran GL. 1996. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 36:280-286.
29. Rajan B, Polydefkis M, Hauer P, Griffin JW, McArthur JC. 2003. Epidermal reinnervation after intracutaneous axotomy in man. J Comp Neurol 457:24-36.
30. Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH. 2003. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse 50:233-239.
31. Rumajogee P, Madeira A, Verge D, Hamon M, Miquel MC. 2002. Up-regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms. J Neurochem 83:1525-1528.
32. Sandvig A, Berry M, Barrett LB, Butt A, Logan A. 2004. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46:225-251.
33. Sato Y, Nakajima S, Shiraga N, Atsumi H, Yoshida S, Koller T, Gerig G, Kikinis R. 1998. Three-dimensional multi-scale line filter for segmentation and visualization of curvilinear structures in medical images. Med Image Anal 2:143-168.
34. Séguéla P, Watkins KC, Descarries L. 1989. Ultrastructural relationships of serotonin axon terminals in the cerebral cortex of the adult rat. J Comp Neurol 289:129-142.
35. Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, Glass DJ, Masiakowski P, Furth ME, Valenzuela DM, DiStefano PS, Yancopoulos GD. 1991. TrkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65:885-893.
36. Thomas CE, Birkett D, Anozie I, Castro MG, Lowenstein PR. 2001. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain. Mol Ther 3:36-46.
37. Tobias CA, Shumsky JS, Shibata M, Tuszynski MH, Fischer I, Tessler A, Murray M. 2003. Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp Neurol 184:97-113.
38. Zhou L, Baumgartner BJ, Hill-Felberg SJ, McGowen LR, Shine HD. 2003. Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J Neurosci 23:1424-1431.